Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000159417 | SCV000209363 | likely benign | not specified | 2011-07-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV002326913 | SCV002633317 | uncertain significance | Cardiovascular phenotype | 2022-01-04 | criteria provided, single submitter | clinical testing | The p.E147* variant (also known as c.439G>T), located in coding exon 4 of the TTR gene, results from a G to T substitution at nucleotide position 439. This changes the amino acid from a glutamic acid to a stop codon within coding exon 4. This alteration is expected to result in premature protein truncation or nonsense-mediated mRNA decay. However, loss of function of TTR has not been clearly established as a mechanism of disease. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005016475 | SCV005652449 | uncertain significance | Hyperthyroxinemia, dystransthyretinemic; Amyloidosis, hereditary systemic 1; Carpal tunnel syndrome 1 | 2024-02-19 | criteria provided, single submitter | clinical testing |